Yilmaz I, Sariboyaci A E, Subasi C, Karaoz E
Center for Stem Cell and Gene Therapies Research and Practice, Institute of Health Sciences, Stem Cell Department, Kocaeli University, Kocaeli, Turkey.
Exp Clin Endocrinol Diabetes. 2016 Feb;124(2):120-9. doi: 10.1055/s-0035-1554720. Epub 2015 Nov 20.
The differentiation capacity of embryonic stem cells (ESCs) has great promise for type-1 diabetes for cellular treatment. Therefore, different strategies have been reported so far for derivation of insulin producing cells (IPCs) from ESCs. Providing similar microenvironmental conditions as in vivo, functional differentiation of stem cells into desired cell types could be obtained in vitro. The aim of the present research was to utilize differentiation potential of ESCs to IPCs by co-culture with mouse pancreatic islets (mPIs) for the first time.
We present an in-direct differentiation protocol which compared with a conventional differentiation protocol. Novel in-direct co-culture differentiation protocol in which mPIs induced differentiation of ESCs into IPCs was used. This technique was compared with the chemical differentiation protocol that involved supplementing the differentiation media with specific growth factors. We analyzed differentiated cells in both groups by immune labelling, gene expression and protein secretion.
IPCs were obtained with in-direct co-culture within 30 days. Differentiated ESCs were found to be positive for IPC specific markers, Pdx1, Insulin, C-peptide, Glut2 and MafA. The results of immunocytochemical and gene expression analysis showed higher differentiation efficiency in co-culture group than chemical differentiation group. These results were confirmed by the response assay to high glucose levels with ELISA for insulin.
Our findings illustrate the significant effect of co-culture in different stages of differentiation and maturation of ESCs in vitro. We have developed an efficient and easy way to differentiate ESCs into IPCs, which possess similar characters of mature insulin positive cells.
胚胎干细胞(ESC)的分化能力在1型糖尿病的细胞治疗方面具有巨大潜力。因此,迄今为止已报道了多种从ESC中诱导产生胰岛素分泌细胞(IPC)的不同策略。通过提供与体内相似的微环境条件,可在体外实现干细胞向所需细胞类型的功能性分化。本研究的目的是首次通过与小鼠胰岛(mPI)共培养,利用ESC向IPC的分化潜能。
我们提出了一种间接分化方案,并与传统分化方案进行比较。采用了一种新型间接共培养分化方案,即mPI诱导ESC分化为IPC。将该技术与在分化培养基中添加特定生长因子的化学分化方案进行比较。我们通过免疫标记、基因表达和蛋白质分泌分析了两组中的分化细胞。
通过间接共培养在30天内获得了IPC。发现分化的ESC对IPC特异性标志物Pdx1、胰岛素、C肽、Glut2和MafA呈阳性。免疫细胞化学和基因表达分析结果显示,共培养组的分化效率高于化学分化组。用ELISA检测胰岛素对高葡萄糖水平的反应试验证实了这些结果。
我们的研究结果表明共培养在体外ESC分化和成熟的不同阶段具有显著作用。我们开发了一种有效且简便的方法,可将ESC分化为具有成熟胰岛素阳性细胞相似特征的IPC。